Evidence map›Paper›PMID 34308259›Full record

ArticleSN comprehensive clinical medicine2021

Frequently Relapsing Post-COVID-19 Immune Thrombocytopenia.

Claudia Serrano, Ignacio Español, Almudena Cascales, José M Moraleda

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in SN comprehensive clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Immune Thrombocytopenia Onset and Relapse During the COVID-19 Pandemic. A Monocenter Study.Mediterranean journal of hematology and infectious diseases · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Claudia SerranoHematology Department, Hematopoietic Stem Cell Transplant and Cell Therapy Unit, Virgen de la Arrixaca University Hospital, IMIB, University of Murcia, Carretera Madrid-Cartagena s/n. 30120, El Palmar, Murcia, Spain.ORCID 0000-0002-9688-6162
Ignacio EspañolHematology Department, Hematopoietic Stem Cell Transplant and Cell Therapy Unit, Virgen de la Arrixaca University Hospital, IMIB, University of Murcia, Carretera Madrid-Cartagena s/n. 30120, El Palmar, Murcia, Spain.ORCID https://orcid.org/0000-0001-5145-7711
Almudena CascalesHematology Department, Hematopoietic Stem Cell Transplant and Cell Therapy Unit, Virgen de la Arrixaca University Hospital, IMIB, University of Murcia, Carretera Madrid-Cartagena s/n. 30120, El Palmar, Murcia, Spain.
José M MoraledaHematology Department, Hematopoietic Stem Cell Transplant and Cell Therapy Unit, Virgen de la Arrixaca University Hospital, IMIB, University of Murcia, Carretera Madrid-Cartagena s/n. 30120, El Palmar, Murcia, Spain.ORCID https://orcid.org/0000-0001-9080-1466

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BleedingITPPost-COVID-19Relapses

Identifiers

PMID34308259
PMCPMC8294309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.